ONCT Chart
- 52-Week Range: $0.70 - $5.80
- Market Capitalization: $43.48M
- Short Percentage: 0%
- Target Price: $9.58
- Shares Outstanding: 49.43M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ONCT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Oncternal Therapeutics to Provide Business Update and Report First Quarter 2022 Financial ResultsGlobeNewsWire | April 28th
- Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | April 1st
- Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | March 1st
- Oncternal Therapeutics Hosting Key Opinion Leader Webinar on Hematological Malignancies and Prostate CancerGlobeNewsWire | January 20th
- Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASH 2021GlobeNewsWire | December 13th
- Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | December 1st
Company Info
Website: https://www.oncternal.com
Address: 12230 El Camino Real, San Diego, CA, United States, 92130
Sector: Healthcare
Industry: Biotechnology
Full time employees: 26
Address: 12230 El Camino Real, San Diego, CA, United States, 92130
Sector: Healthcare
Industry: Biotechnology
Full time employees: 26
$ONCT Holding Strong since January ??????????
$ONCT I like the stock!
$ONCT hopefully next week...
$ONCT Just buy and hold
$ONCT here to raid
$ONCT good place to average up
$ONCT Silly Bears tricks are for kids
$ONCT Don't hold!!! Buy it
$ONCT Hold on to your Butts.
$ONCT gonna take my L with this one